Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 3,730,000 shares, a decrease of 6.8% from the September 30th total of 4,000,000 shares. Approximately 12.1% of the company’s shares are short […]
Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Monte Rosa Therapeutics (GLUE) Announces 10M Share Offering at $2.50/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) – Equities researchers at Leerink Partnrs raised their FY2023 EPS estimates for shares of Monte Rosa Therapeutics in a note issued to investors on Tuesday, October 17th. Leerink Partnrs analyst C. Liu now forecasts that the company will earn ($1.75) per share for the year, up from […]
Monte Rosa Therapeutics Announces Strategic Collaboration with Roche to Discover Novel Molecular Glue Degraders Targeting Cancer and Neurological Diseases streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.